Home> Announcements> International topics> Trilateral Cooperation (JPO-EPO-USPTO)> Trilateral Project 24.1-Biotechnology> Trilateral Project 24.1-Biotechnology 046
Main content starts here.
Broad claims concerning hybridoma cell lines producing a monoclonal antibody can be characterized by their parental cells, the antigen used for raising the antibody and the function of the hybridoma cell lines, namely to produce a monoclonal antibody against said specified antigen.
Narrow claims to specific hybridoma cell lines should be characterized by reference to their deposit numbers (see 2.2(6) and 2.3(5)).